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Background: Th2-type T cell response has a considerable role in atopic diseases. The involvement of Th17 and IL-17
in atopy process provided new understanding of allergic diseases. Bronchial hyperresponsiveness is quite common in
allergic rhinitis. We aimed to explore the expression of IL-17 producing CD3+ CD4+ T cells in peripheral blood of rhinitic
patients, with/without bronchial hyperresponsiveness and sensitized to common allergens, as this relationship has not
been examined.
Methods: Sixty one patients with allergic rhinitis and thirty controls were examined. IL-17 producing T cells were
detected by flow cytometry, IL-17, IL-4 and IL-13 levels in peripheral blood were evaluated by ELISA. Bronchial
hyperresponsiveness was investigated with methacholine challenge test. Atopy was evaluated by skin prick
tests with common allergens.
Results: IL-17 producing T cell percentage of AR group was significantly higher: 2.59 ± 1.32 than in controls
1.24 ± 0.22, (p = 0.001). Significant sex related difference in CD3+ CD4+ IL-17 T cells was observed: respectively in
male patients versus female 3.15 ± 1.8% and 2.31 ± 0.9%, (p = 0.02). Rhinitics had greater bronchodilator responses
compared to controls (p = 0.001), however the percentages of T cells in both groups appeared equal. Serum IL-17
levels in AR group were significantly higher (5.10 ± 4.40) pg/ml than in controls (3.46 ±1.28) pg/ml, (p = 0.04). IL-4 levels
(0.88 ± 1.27) and IL-13 levels (3.14 ± 5.85) in patients were significantly higher than in control’s (0.54 ± 0.10) pg/ml,
(p = 0.001) and (1.19 ± 0.64) pg/ml; (p = 0.001) respectively.
The percentages of T cells in patients sensitized to 5 allergens (group I) were significantly lower (1.91 ± 0.62) than those
sensitized to more than 5 allergens (group II) (2.91 ± 1.5) (p = 0.004).
Conclusions: The observed higher levels of IL-17 producing T cells in polysensitized males suggest a role of IL-17 in
pathogenesis of AR. The higher airway responsiveness in AR may not be Th17 dependent. The higher serum values of
IL-17, IL-4 and IL-13 demonstrate the presence of cytokine balance in atopic diseases.
Keywords: IL-17, Th17, IL-4, IL-13, Allergic rhinitis, Atopy, Bronchial hyperresponsiveness* Correspondence: vmtsvetkova@abv.bg
1Department of Clinical Laboratory, Clinical Immunology and Allergology,
Medical University of Pleven, Pleven, Bulgaria
Full list of author information is available at the end of the article
© 2014 Tsvetkova-Vicheva et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Tsvetkova-Vicheva et al. Clinical and Translational Allergy 2014, 4:3 Page 2 of 7
http://www.ctajournal.com/content/4/1/3Background
A trend of increasing prevalence of allergic rhinitis (AR)
worldwide keeps the interest in investigation of patho-
genesis of the disease. Th2 cells are suspected as the key
culprit in the pathophysiology of atopic disorders [1].
Interleukin 17A (IL-17A), commonly known as IL-17, is
produced by T helper 17 (Th17) subset of CD4+ T cells.
Recent progress in Th17 cells knowledge suggests a
pathological role of IL-17 in the allergic responses [2].
However, the involvement of Th17 cells in AR has not been
clearly examined [3]. Th2 cells produce IL-4 and IL-13 and
mediate allergic responses and these cytokines have been
extensively studied as key players in the atopic airway
diseases. The roles of IL-4 in IgE production and IL-13 in
bronchial hyperresponsiveness (BHR) and tissue remodel-
ing are evident [1]. Th17 cells and IL-17 as a major family
cytokine are usually associated with autoimmune reac-
tion or neutrophil inflammation. Nevertheless it has
been demonstrated that allergic sensitization through
the airway promotes strong Th17 response and acute
BHR in mouse model of asthma [4]. Asymptomatic air-
way hyperreactivity is common in people with AR, but
the immunological mechanisms have to be defined.
There are no data presenting the intimate role of Th17
cells in these events. Based on this, we hypothesized that
IL-17 may mediate airway hyperresponsiveness in AR
patients.
The present study examined the immunologic charac-
teristics of sensitized patients with allergic rhinitis with/




Sixty one subjects (41 females and 20 males, mean age
36.25 ± 5 years) with persistent moderate-to-severe aller-
gic rhinitis and thirty healthy controls (18 females and
12 males, mean age 35.73 ± 6 years) were included in the
study. The subjects were selected by detailed clinical
history of nasal obstruction, and/or rhinorrhea, sneezing,
itching and sensitization to one perennial allergen at least.
Selected patients experienced these symptoms since at
least two years. Exclusion criteria were: bronchial asthma,
chronic rhinosinuitis, nasal polyposis, excessive septal de-
viation and current smoking.
Blood samples for assessment of cytokines, IL-17 produ-
cing T cells and peripheral eosinophil counts were taken
from patients and controls. The study was approved
by the ethic committee of MU-Pleven, Bulgaria. Informed
consent was obtained from all the subjects.
Atopy assesment
The skin prick tests (SPT) were performed to patients
and controls according to the method of Pepys [5].The patients were not under antihistamine treatment
since at least 10 days before skin prick tests. The follow-
ing allergens (Stallergens) were used: House dust mites:
(dermatophagoides pteronyssinus, dermatophagoides
farinae), Animal feather (feathers mixture: duck, goose,
hen), cat, dog, Grass mix (3 grasses: dactylis glomerata,
lolium perenne, phleum pratense), Grass mix (5 grasses:
dactylis glomerata, lolium perenne, phleum pratense,
anthoxanthum odoratum, poa pratensis ), Grass mix (4
cereals: avena sativa, triticum vulgare, zea mays, hard-
eum vulgare), Grass mix (12 grasses: holcus lanatus,
festuca elatior, cynodon dactylon, bromus hordeaceus,
avena fatua, arrhenatherum elatius, agrositis vulgaris,
dactylis glomerata, lolium perenne, phleum pratense,
anthoxanthum odoratum, poa pratensis), Trees: Beech
(Fagaceae: castanea vulgaris, quercus robur, fagus syl-
vatica), Birch (Betulaceae: alnus glutinosa, betula alba,
carpinus betulus, corylus avellona), Willow (Salicaceae:
populus alba, salix caprea), Weeds (Ragweed, artemisia
vulgaris), Molds (alternaria alternata, aspergillus mix,
fusarium solani, penicillium mix) and Cockroach. His-
tamine solution (10 mg/mL) and saline served as positive
and negative control respectively. The size of the wheal
was measured after 15 min. Diameter of ≥3 mm was con-
sidered as a positive reaction.
Direct bronchial challenge testing with methacholine
Methacholine provocation test was performed according
to the 2-min tidal breathing method and inhalation of
an aerosol from a nebulizer at an output of 0.13 mL/min
was used. Saline was used as control. The concentra-
tions of methacholine from 0.03 to 16 mg/ml [6] were
used. Forced expiratory volume for one sec (FEV1) was
measured at 30 and 90 sec after completed two minutes
inhalation preceded by baseline spirometry. An acceptable-
quality FEV1 was obtained at each time point. The test
was discontinued when a drop of 20% in FEV1 occurred.
The protocol included a post-bronchodilator test. The pa-
tients and controls were consistent with the following
criteria: nonsmokers and FEV1 ≥80% of predicted values
before testing.
A modified version of English Wright nebulizer and
Spirometer “Spirovit sp-10” (Schiller, Switzerland) were
used.
Expression of IL-17A in peripheral blood T lymphocytes
Blood sample collection and PMBC culture
Blood samples from studied subjects were collected in
EDTA vacutainer (Becton Dickinson, USA) and used for
peripheral blood mononuclear cells (PBMC) isolation.
PMBC were obtained by centrifugation on Ficoll-Paque
Plus (GE Healthcare, Sweden) and resuspended in 10%
FBS-RPMI 1640 (Invitrogen). Cells were cultured in pres-
ence of 50 ng/ml Phorbol Myristate Acetate (PMA) (Sigma)
Table 1 Baseline characteristics of study subjects
Controls AR patients Total p




Age (year) 35.73 ± 6 36.25 ± 5 36.08 ± 6
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protein transport inhibitior (GolgiPlug, Becton Dickinson)
was added followed by consequent incubation and wash-
ing procedures.
Intracellular staining of IL-17A cytokine
Cells were stained for cell surface markers with Anti-
Human CD3 PerCP (Becton Dickinson) and MAB FITC-
anti-human CD4 (Becton Dickinson) followed by fixation
and permeabilization with Cytofix/Cytoperm. MAB PE
anti-human IL-17A (Becton Dickinson Pharmingen) for
the intracellular cytokine staining was used. After washing
with PBS and 1% formaldehyde fixation, blood sam-
ples were stored at 40C prior to flow cytometry. Isotype
control was included in each assay. Flow cytometer FAC-
Sort model (Becton Dickinson) was used. Results were
expressed in percentages.
In vitro determination of IL-4, IL-13 and IL-17
Specimen collection
Five ml of peripheral blood were collected using pyrogen/
endotoxin free collecting tubes from all subjects (patients
and controls). Serum was removed rapidly and carefully
from the red cells after clotting followed by centrifuge at
approximately 1000 × g for 10 min.
IL-4, IL-13 and IL-17 levels in serum were analyzed
using commercially available pre-coated enzyme-linked –
immunosorbent –assay (ELISA) kits (Diaclone SAS, France).
All reagents were brought to room temperature before
use. Preparation of Wash Buffers, Standard Diluent
Buffers and Controls followed the instructions in the man-
ufacturer’s manual. After the final preparation of all re-
agents, the average absorbance values for each set of
triplicate standards, controls and samples were calcu-
lated within 20% of the mean. A linear standard curve
was generated. The amounts of IL-4, IL-13 and IL-17 in
each sample were determined by extrapolating OD values
using a standard curve. The lower limit of detection
was <0.54 pg/ml for IL-4, <1.17 pg/ml for IL-13 and <3.2
pg/ml for IL-17.
Statistical analysis
Variables with normal distribution were expressed as
mean and standard deviation.
For comparison of two independent groups the non-
parametric Mann–Whitney U test was used.
Statistical analysis was performed using SPSS (version
19.1). The results were expressed as mean ± standard de-
viation (SD). P <0.05 was considered as significant.
Results
Demographic characteristics of study population
A total of 91 subjects (61 patients and 30 controls) age
matched were included in the study. Demographic dataof AR group and controls are presented on Table 1, as
well as eosinophil (Eo) count and BHR.
IL-17 producing T cells in peripheral blood were higher in
AR patients
Average percentages of IL-17 producing T cells determined
with flow cytometer were between 0.57 to 1.84% in healthy
subjects and 1.34 to 6.84% in the patients (Figure 1).
The percentage of IL-17 producing T cells in PMBC
from whole blood of allergic rhinitis patients was signifi-
cantly increased (2.59 ± 1.32%) as compared to controls
(1.24 ± 0.22%) (p = 0.001) (Figure 2).
IL-17 producing T cells were higher in males in both
groups of rhinitics and controls
The gender related experimental outcome was assessed.
In the study, 64.8% of the subjects were women. The
percentages of CD3+ CD4+ IL-17 T cells were signifi-
cantly higher in male patients: 3.15 ± 1.81 versus 2.31 ±
0.91 in females (p = 0.02) (Figure 3).
IL-17 expression was dependent on sensitization rate
Table 2 presents the relationship between average per-
centages of Th17 expressing IL-17 and different perennial
(indoor) allergens in patients and controls. Table 3 shows
identical correlation with outdoor allergens (Table 3).
In terms of skin-prick test results patients were assigned
as: group I - sensitized to five allergens and group II - sen-
sitized to more than 5 allergens. The average of IL-17 pro-
ducing T cells percentages in two groups was significantly
different: 1.91 ± 0.62% for group one and 2.91 ± 1.5% for
group two (p = 0.004) (Figure 4).
Increased levels of IL-4, IL-13 and IL-17 in AR patients
To elucidate the role of IL-17 in allergic inflammation in
parallel with the classical participants (IL-4 and IL-13), all
of them (IL-4, IL-13 and IL-17) were analyzed by ELISA
method in the patients and controls.
The mean values in healthy subjects were within the
normal ranges closely related to the available in the manu-
facturer’s manual. The mean levels in healthy controls
were: 0.54 pg/ml (IL-4), 1.17 pg/ml (IL-13), and 3.2 pg/ml
Figure 1 PMBCs isolated from controls and allergic rhinitis patients were stimulated with PMA and Brefeldin A for 5 hours followed by
adding MAB FITS anti-human CD4 and anti-human CD3 PerCP. Production of IL-17 by PBMCs was determined at the single-cell level by
intracellular cytokine staining and flow cytometric analysis. The upper right quadrants represent the percentage of IL-17 T cells with expression of
CD3 and CD4 cells in the total lymphocyte populations gated. The dot plots show CD4 T cells producing IL-17 in human peripheral
blood lymphocytes from healthy controls (A) and rhinitics (B).
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values above these characters were accepted as patho-
logical (Figure 5). The average values for IL-4, IL-13 and
IL-17 levels were higher in patients compared to controls.
IL-4 levels were significantly higher (0.88 ± 1.27) pg/ml in
patients versus (0.54 ± 0.10) pg/ml in controls, (p = 0.001).
The mean values were significantly higher for IL-13 in
rhinitics (3.14 ± 5.85) pg/ml and (1.19 ± 0.64) pg/ml in
healthy subjects, (p = 0.001).
The mean values of IL-17 were significantly higher in
patients (5.10 ± 4.40) pg/ml as compared to asymptom-
atic subjects (3.46 ±1.28) pg/ml, (p = 0.04).
There was a significant difference between AR group
and healthy subjects for all investigated interleukins.
Table 4 presents the association between each aeroal-
lergen causing symptoms throughout the year and serum
levels of IL-4, IL-13 and IL-17. The perennial allergens
of house dust mites correlate significantly with the three
interleukins. Animal feather allergen is strongly associ-





















Figure 2 IL-17 producing CD4+ T cells in AR patients and
control subjects measured by flow cytometry (%).The data of blood levels of the studied variables (IL-4,
IL-13 and IL-17) and outdoor allergens are shown in
Table 5. The average mean values of IL-4 showed signifi-
cantly higher levels in patients sensitized to birch and
beech pollens. IL-13 blood concentrations were signifi-
cantly higher in beech sensitized rhinitics. There was no
significant difference in IL-17 serum levels for outdoor
allergens.
Patients who were sensitized to birch and beech aller-
gens showed significantly higher values of IL-4. IL-13
was significantly higher in patients with positive SPT to
beech pollen.
Allergic rhinitis patients were hyperresponsive to
methacholine independently of IL-17 producing T cells
In comparison with healthy subjects, those with AR
had a higher degree of bronchial responsiveness to me-























Figure 3 IL-17 producing CD4+ T cells in male and female AR
patients measured by flow cytometry (%).
Table 2 Mean percentages of IL-17 producing T cells in
patients and controls, measured by flow cytometry,
corresponding with inhalant perennial allergens
Allergen Mean values of IL-17
producing T cells in
patients (%)
Mean values of IL-17
producing T cells in
controls (%)
D. pteronyssinus* 2.59 ± 1.45 1.25 ± 0.00
D. farinae* 2.57 ± 1.26 1.24 ± 0.01
Animal feather 2.63 ± 1.33 1.23 ± 0.00
Cat 3.46 ± 1.7 1.31 ± 0.08
Dog 3.91 ± 1.88 1.25 ± 0.01
Alternaria alternata 3.04 ± 1.33 1.22 ± 0.06
Aspergillus mix 2.65 ± 1.10 0.00
Fusarium solani 2.22 ± 0.55 1.26 ± 0.00
Penicillium mix 3.17 ± 0.92 0.00
Cockroach 2.51 ± 1.08 1.3 ± 0.00
*p < 0.05.
There was no significant difference in percentage of IL-17 producing T cells


























Figure 4 IL-17 producing CD4+ T cells in patients sensitized to
5 allergens (group I) and rhinitics sensitized to more than 5
allergens (group II) measured by flow cytometry (%).
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(CD3+CD4+) in methacholine positive and methacholine
negative rhinitics appeared equal (p > 0.05).
The percentages of T cells in patients sensitized to 5
allergens (group I) were significantly lower (1.91 ± 0.62)
than those sensitized to more than 5 allergens (group II)
(2.91 ± 1.5) (p = 0.004).
Discussion
This study shows that increased levels of IL-17 produ-
cing T cells may play role in the allergic inflammation in
patients with AR. Our observations suggest that IL-17
production might be triggered by the increasing num-
ber of sensitizations. In the pathophysiology of aller-
gic rhinitis, a sensitization process includes activation of
allergen-specific T cells commonly presented by Th2Table 3 Mean percentages of IL-17 producing T cells in
patients and controls, measured by flow cytometry,
corresponding with inhalant pollen allergens
Allergen Mean values of IL-17
producing T cells in
patients (%)
Mean values of IL-17
producing T cells in
controls (%)
3 grasses 3.42 ± 1.61 1.22 ± 0.00
5 grasses 3.31 ± 1.62 1.22 ± 0.00
4 cereals 3.57 ± 1.63 1.22 ± 0.00
12 grasses 2.77 ± 1.05 1.22 ± 0.00
Birch 2.50 ± 0.82 1.22 ± 0.00
Beech 2.99 ± 1.33 0.00
Willow 3.87 ± 1.66 0.00
Ragweed 2.81 ± 0.65 0.00
Artemisia vulgaris 3.81 ± 2.20 0.00subtype. The specific T cells stimulate the production of
allergen-specific IgE which is the essential issue in AR [7].
A recent study on IgE production in human B cells found
that IL-17 could induce B cells switching to IgE which
implies Th17 involvement in the atopic phenomenon
[8]. The role of IL-17 producing cells as the subject of re-
search in the field of allergic sensitization is essential
not only for increasing our understanding of the AR
mechanism. The process of polysensitization is associ-
ated with substantial impact on quality of life of rhinitis
patients [9]. It has been reported that polysensitized sub-
jects experienced more severe symptoms than monosensi-
tized ones [9] and frequently presented associated asthma.
These clinical implications make the recognition of IL-17
as being important in the pathogenesis of allergic rhinitis.
Furthermore, we examined IL-17 dependent BHR in
AR patients for the first time. The results obtained show
that subjects with BHR to methacholine exhibit simi-
lar percentages of IL-17 producing T cells as methacholine
negative patients.
Yet, the subjects with asymptomatic BHR differed sig-
nificantly from healthy controls.
It would be important to follow up the AR patients













Figure 5 IL-4, IL-13 and IL-17 levels in allergic rhinitis patients
and healthy subjects measured by ELISA.
Table 4 Mean values of IL-4, IL-13 and IL-17 in patients and controls, measured by ELISA, corresponding with inhalant
perennial allergens
IL-4 IL-13 IL-17












D. pteronyssinus 3.16 ± 2.73* 1.53 ± 2.09 3.21 ± 2.67* 1.38 ± 2.11 3.24 ± 2.77* 2.15 ± 2.46
D. farinae 2.31 ± 2.38* 1.30 ± 1.93 2.26 ± 2.32 1.38 ± 2.11 2.52 ± 2.43 1.61 ± 2.09
Animal feather 0.51 ± 1.36* 0.00 0.50 ± 1.35* 0.00 0.43 ± 1.36 0.28 ± 0.93
Cat 0.70 ± 1.99 0.20 ± 0.76 0.58 ± 1.91 0.44 ± 1.15 0.48 ± 1.66 0.63 ± 1.81
Dog 0.52 ± 1.70 0.33 ± 1.03 0.53 ± 1.71 0.31 ± 0.93 0.52 ± 1.77 0.43 ± 1.29
Alternaria alternata 0.72 ± 1.73 0.70 ± 1.64 0.77 ± 1.77 0.59 ± 1.55 0.45 ± 1.27 1.00 ± 2.02
Aspergillus mix 0.56 ± 1.47 0.20 ± 1.09 0.55 ± 1.46 0.21 ± 1.11 0.71 ± 1.64 0.22 ± 1.05
Fusarium solani 0.47 ± 1.35 0.27 ± 1.05 0.55 ± 1.46 0.10 ± 0.56 0.52 ± 1.47 0.33 ± 1.08
Penicillium mix 0.31 ± 1.07 0.00 0.31 ± 1.06 0.00 0.29 ± 1.07 0.15 ± 0.73
Cockroach 0.10 ± 0.54 0.23 ± 0.90 0.15 ± 0.65 0.14 ± 0.74 0.21 ± 0.78 0.09 ± 0.59
*p < 0.05.
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the succeeding few years.
The role of IL-13 in mediating lower airway inflamma-
tion and BHR following isolated allergic sensitization of
the upper airways was suggested in a recent study of Wang
et al. [10]. The authors highlighted the role of interleukins
in the communication between the upper and lower air-
ways. Notwithstanding the recent evidence suggesting
IL-17 contribution to BHR [11], raised new and com-
plex questions. Data for IL-17 mediated allergic rhin-
itis in humans are quite limited compared to murine
experimental models. Moreover, recent studies have been
demonstrated that cytokine setting inducing Th17 differ-
entiation in humans and mice is different [12]. The
same authors state the role of IL-17 producing cells
in allergic reactions as “largely unclear”. In 2010 forTable 5 Mean values of IL-4, IL-13 and IL-17 in patients and c
(measured by ELISA)
IL-4






3 grasses 1.95 ± 3.10 1.00 ± 2.41 1.85 ± 3.11
5 grasses 1.67 ± 2.63 1.03 ± 2.53 1.60 ± 2.69
4 cereals 1.79 ± 3.10 1.03 ± 2.53 1.73 ± 3.16
12 grasses 0.36 ± 1.27 0.43 ± 1.36 0.48 ± 1.42
Birch 1.69 ± 3.10* 0.50 ± 1.38 1.48 ± 3.02
Beech 1.18 ± 2.28* 0.27 ± 1.05 1.19 ± 2.24*
Willow 0.52 ± 1.70 0.00 0.44 ± 1.58
Ragweed 0.16 ± 0.90 0.13 ± 0.73 0.16 ± 0.89
Artemisia
vulgaris
0.25 ± 1.15 0.00 0.24 ± 1.14
*p < 0.05.the first time IL-17 have been found to play a causa-
tive role in airway remodeling in asthmatic mouse
model [13]. But the idea on participation of IL-17 in
upper airway tissue remodeling is not clear and is still
controversial.
Furthermore, we demonstrate that rhinitic subjects
display high levels of IL-4, IL-13 and IL-17 in peripheral
blood. IL-4 and IL-13 are key players in the allergic re-
sponse [1] as it was confirmed in our study also. Despite
missing information on Th2 expression in this study,
both IL-4 and IL-13 served as important indicators of
Th2 expression. Recent studies demonstrated that both
Th2 and Th17 are involved in the pathogenesis of aller-
gic airway inflammation through releasing specific cyto-
kines [14]. IL-13 is essential for the development of a









1.17 ± 2.41 2.31 ± 2.99 1.13 ± 2.81
1.17 ± 2.41 2.02 ± 2.87 1.04 ± 2.33
1.14 ± 2.37 1.98 ± 3.22 1.24 ± 2.71
0.17 ± 0.93 0.52 ± 1.50 0.28 ± 1.11
0.90 ± 1.86 1.88 ± 3.32 0.78 ± 1.98
0.21 ± 1.11 1.19 ± 2.21 0.65 ± 1.83
0.17 ± 0.93 0.31 ± 1.16 0.41 ± 1.65
0.14 ± 0.74 0.21 ± 0.98 0.11 ± 0.74
0.00 0.29 ± 1.31 0.07 ± 0.44
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response [1]. The Th17 subset discovery revised the
Th1/Th2 paradigm and enhanced the understanding of
heterogeneous nature of allergic disease [1].
The limitation of this study is relatively small number of
control subjects experienced to methacholine and skin
prick tests, which could be overcome in a future study.
Conclusions
The higher levels of IL-17 producing CD3+CD4+T cells
in peripheral blood of polysensitized allergic rhinitis pa-
tients were demonstrated.
The increased BHR in AR subjects and their airway
response was suggested to enhance upon natural ex-
posure to multiple allergens to which the subjects were
sensitized.
The role in allergic inflammation of Th2 associated cy-
tokines was confirmed.
Settings of high levels of IL-4, IL-13 and IL-17 in AR
subjects on multiple allergen exposure support the idea of
the heterogeneous nature of allergic disease and the role
of Th1/Th2/Th17 balance in the pathogenesis of AR.
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